Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Published in: Journal of Nuclear Cardiology 3/2004

01-05-2004 | Original Articles

The prognostic value of ECG-gated SPECT imaging in patients undergoing stress Tc-99m sestamibi myocardial perfusion imaging

Authors: Mark I. Travin, Gary V. Heller, Lynne L. Johnson, Deborah Katten, Alan W. Ahlberg, Carmen R. Isasi, Robert C. Kaplan, Cynthia C. Taub, Diane Demus

Published in: Journal of Nuclear Cardiology | Issue 3/2004

Login to get access
Metadata
Title
The prognostic value of ECG-gated SPECT imaging in patients undergoing stress Tc-99m sestamibi myocardial perfusion imaging
Authors
Mark I. Travin
Gary V. Heller
Lynne L. Johnson
Deborah Katten
Alan W. Ahlberg
Carmen R. Isasi
Robert C. Kaplan
Cynthia C. Taub
Diane Demus
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 3/2004
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1016/j.nuclcard.2004.02.005

Other articles of this Issue 3/2004

Journal of Nuclear Cardiology 3/2004 Go to the issue

OriginalPaper

Role of molecular imaging in defining and denying death…

OriginalPaper

Automatic quantification of right ventricular function with gated blood pool SPECT

Events

Calendar

News

Asnc news

OriginalPaper

Clinical value of attenuation correction in stress-only Tc-99m sestamibi SPECT imaging

BookReview

Book reviews

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits